Allergy to Cats: Current Perspectives and Therapeutic Options

Area of Science:

• Immunology
• Allergology
• Environmental Health

Background:

• Cat dander allergens cause significant allergic rhinitis (AR) and asthma, with high prevalence worldwide.
• Exposure to cat allergens like Fel d 1 and Fel d 4 is pervasive, impacting even non-cat owners.
• Current management via avoidance and pharmacotherapy is often insufficient for severe cases.

Purpose of the Study:

• To review the current landscape of cat allergen immunotherapy (AIT).
• To explore challenges and advancements in AIT for cat-induced allergic diseases.
• To highlight the need for improved AIT strategies and personalized treatment.

Main Methods:

• Literature review of cat allergens and immunotherapy approaches.
• Analysis of existing challenges in AIT efficacy and prescription rates.
• Exploration of novel AIT formulations and adjunctive therapies.

Main Results:

• Fel d 1 and Fel d 4 are key allergens in cat-induced asthma and AR.
• AIT (SLIT and SCIT) offers disease modification but faces limitations in potency and standardization.
• Newer AIT formulations including Fel d 4 and novel antigen presentation methods show potential.
• Combination therapies with monoclonal antibodies may improve AIT effectiveness and safety.

Conclusions:

• Improved AIT formulations and personalized care are crucial for managing cat allergies.
• Component-resolved diagnostics are essential for tailoring AIT to individual sensitization profiles.
• Enhanced physician and patient education is vital for wider AIT adoption and treatment success.